GLAZER CAPITAL, LLC - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 41 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$8,702
+4.6%
850,590
+2.7%
0.48%
+121.4%
Q4 2022$8,322
-99.8%
828,060
+85.7%
0.22%
+168.8%
Q3 2022$4,387,000
+568.8%
445,825
+561.8%
0.08%
+400.0%
Q2 2022$656,000
+139.4%
67,365
+139.0%
0.02%
+100.0%
Q1 2022$274,00028,1810.01%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2022
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 141,317$1,448,4992.02%
Atalaya Capital Management LP 500,000$5,115,0001.63%
MMCAP International Inc. SPC 800,000$8,184,0001.61%
ANGELO GORDON & CO., L.P. 300,000$3,069,0000.77%
FIR TREE CAPITAL MANAGEMENT LP 792,269$8,104,9120.64%
Castle Creek Arbitrage, LLC 530,000$5,421,9000.60%
683 Capital Management, LLC 699,000$7,150,7700.53%
GLAZER CAPITAL, LLC 850,590$8,7020.48%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$5,125,0000.45%
METEORA CAPITAL, LLC 366,183$3,746,0520.44%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders